Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2011, Article ID 629234, 9 pages
http://dx.doi.org/10.1155/2011/629234
Research Article

A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect

1Drug Delivery Lab, Biomedical Engineering Research Laboratories, Industrial Technology Research Institute, Hsinchu 31040, Taiwan
2Medical College and Hospital, National Cheng Kung University, Tainan 701, Taiwan

Received 24 June 2010; Revised 14 September 2010; Accepted 17 September 2010

Academic Editor: Kozo Takayama

Copyright © 2011 Pei Kan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Terwogt, B. Nuijen, W. W. Huinink, and J. H. Beijnen, “Alternative formulations of paclitaxel,” Cancer Treatment Reviews, vol. 23, no. 2, pp. 87–95, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-F. Shieh, I.-M. Chu, C.-J. Lee, P. Kan, D.-M. Hau, and J.-J. Shieh, “Liposomal delivery system for taxol,” Journal of Fermentation and Bioengineering, vol. 83, no. 1, pp. 87–90, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. A. O. Nornoo and D. S.-L. Chow, “Cremophor-free intravenous microemulsions for paclitaxel. II. Stability, in vitro release and pharmacokinetics,” International Journal of Pharmaceutics, vol. 349, no. 1-2, pp. 117–123, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. Kan, Z.-B. Chen, C.-J. Lee, and I.-M. Chu, “Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system,” Journal of Controlled Release, vol. 58, no. 3, pp. 271–278, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Bilensoy, O. Gürkaynak, M. Ertan, M. Şen, and A. A. Hincal, “Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel,” Journal of Pharmaceutical Sciences, vol. 97, no. 4, pp. 1519–1529, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. Liu, D. Meisner, E. Kwong, X. Y. Wu, and M. R. Johnston, “A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres,” Biomaterials, vol. 28, no. 21, pp. 3236–3244, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. E. K. Park, S. B. Lee, and Y. M. Lee, “Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs,” Biomaterials, vol. 26, no. 9, pp. 1053–1061, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. Pan and S.-S. Feng, “Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles,” Biomaterials, vol. 29, no. 17, pp. 2663–2672, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. B. B. Lundberg, V. Risovic, M. Ramaswamy, and K. M. Wasan, “A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration,” Journal of Controlled Release, vol. 86, no. 1, pp. 93–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Tartis, J. McCallan, A. F. H. Lum et al., “Therapeutic effects of paclitaxel-containing ultrasound contrast agents,” Ultrasound in Medicine and Biology, vol. 32, no. 11, pp. 1771–1780, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M.-H. Bartoli, M. Boitard, H. Fessi et al., “In vitro and in vivo antitumoral activity of free, and encapsulated taxol,” Journal of Microencapsulation, vol. 7, no. 2, pp. 191–197, 1990. View at Google Scholar · View at Scopus
  12. R. M. Straubinger, A. Sharma, M. Murray, and E. Mayhew, Taxol formulation, US patent 5415869, 1995.
  13. F. Sampedro, J. Partika, P. Santalo, A. M. Molins-Pujol, J. Bonal, and R. Perez-Soler, “Liposomes as carriers of different new lipophilic antitumour drugs: a preliminary report,” Journal of Microencapsulation, vol. 11, no. 3, pp. 309–318, 1994. View at Google Scholar · View at Scopus
  14. A. Sharma and R. M. Straubinger, “Novel taxol formulations: preparation and characterization of taxol-containing liposomes,” Pharmaceutical Research, vol. 11, no. 6, pp. 889–896, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. K. S. Warner, S. Kevin Li, and W. I. Higuchi, “Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes,” Journal of Pharmaceutical Sciences, vol. 90, no. 8, pp. 1091–1105, 2001. View at Publisher · View at Google Scholar · View at PubMed
  16. R. Reszka, M. Brandl, I. Fichtner, and G. Warnke, “Liposome-encapsulated Taxol, its preparation and its use,” US patent 6090955, 2000.
  17. D. Sharma, T. P. Chelvi, J. Kaur, and R. Ralhan, “Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma,” Melanoma Research, vol. 8, no. 3, pp. 240–244, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Boni and J. Portnoff, “Taxane-containing phosphatidylcholine liposomes,” US patent 5683715, 1997.
  19. C. Bernsdorff, R. Reszka, and R. Winter, “Interaction of the anticancer agent Taxol(TM) (paclitaxel) with phospholipid bilayers,” Journal of Biomedical Materials Research, vol. 46, no. 2, pp. 141–149, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio, and L. Cattel, “Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes,” Journal of Controlled Release, vol. 63, no. 1-2, pp. 19–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Cabanes, K. E. Briggs, P. C. Gokhale, J. A. Treat, and A. Rahman, “Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel,” International Journal of Oncology, vol. 12, no. 5, pp. 1035–1040, 1998. View at Google Scholar · View at Scopus
  22. J. Korlach, P. Schwille, W. W. Webb, and G. W. Feigenson, “Characterization of lipid bilayer phases by confocal microscopy and fluorescence correlation spectroscopy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8461–8466, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. M. C. Alley, D. A. Scudiero, A. Monks et al., “Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay,” Cancer Research, vol. 48, no. 3, pp. 589–601, 1988. View at Google Scholar · View at Scopus
  24. H.-H. Yeh, W.-W. Lai, H. H. W. Chen, H.-S. Liu, and W.-C. Su, “Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion,” Oncogene, vol. 25, no. 31, pp. 4300–4309, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. M. Koziara, T. R. Whisman, M. T. Tseng, and R. J. Mumper, “In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors,” Journal of Controlled Release, vol. 112, no. 3, pp. 312–319, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. L. Klibanov, K. Maruyama, V. P. Torchilin, and L. Huang, “Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes,” FEBS Letters, vol. 268, no. 1, pp. 235–237, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. Zhang, G. Anyarambhatla, L. Ma et al., “Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 59, no. 1, pp. 177–187, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. V. Balasubramanian, J. L. Alderfer, and R. M. Straubinger, “Solvent- and concentration-dependent molecular interactions of taxol (Paclitaxel),” Journal of Pharmaceutical Sciences, vol. 83, no. 10, pp. 1470–1476, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. M. R. Wenk, A. Fahr, R. Reszka, and J. Seelig, “Paclitaxel partitioning into lipid bilayers,” Journal of Pharmaceutical Sciences, vol. 85, no. 2, pp. 228–231, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. L. A. Bagatolli and E. Gratton, “Two photon fluorescence microscopy of coexisting lipid domains in giant unilamellar vesicles of binary phospholipid mixtures,” Biophysical Journal, vol. 78, no. 1, pp. 290–305, 2000. View at Google Scholar · View at Scopus
  31. C. Gliss, H. Clausen-Schaumann, R. Günther, S. Odenbach, O. Randl, and T. M. Bayerl, “Direct detection of domains in phospholipid bilayers by grazing incidence diffraction of neutrons and atomic force microscopy,” Biophysical Journal, vol. 74, no. 5, pp. 2443–2450, 1998. View at Google Scholar · View at Scopus
  32. I. P. Sugár, T. E. Thompson, and R. L. Biltonen, “Monte Carlo simulation of two-component bilayers: DMPC/DSPC mixtures,” Biophysical Journal, vol. 76, no. 4, pp. 2099–2110, 1999. View at Google Scholar · View at Scopus
  33. J. Y. A. Lehtonen, J. M. Holopainen, and P. K. J. Kinnunen, “Evidence for the formation of microdomains in liquid crystalline large unilamellar vesicles caused by hydrophobic mismatch of the constituent phospholipids,” Biophysical Journal, vol. 70, no. 4, pp. 1753–1760, 1996. View at Google Scholar · View at Scopus
  34. A. Sharma, E. Mayhew, L. Bolcsak et al., “Activity of paclitaxel liposome formulations against human ovarian tumor xenografts,” International Journal of Cancer, vol. 71, no. 1, pp. 103–107, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Treat, N. Damjanov, C. Huang, S. Zrada, and A. Rahman, “Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel,” ONCOLOGY, vol. 15, no. 5, pp. 44–48, 2001. View at Google Scholar · View at Scopus
  36. L. Brannon-Peppas and J. O. Blanchette, “Nanoparticle and targeted systems for cancer therapy,” Advanced Drug Delivery Reviews, vol. 56, no. 11, pp. 1649–1659, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. G. J. Fetterly and R. M. Straubinger, “Pharmacokinetics of paclitaxel-containing liposomes in rats,” AAPS PharmSci, vol. 5, no. 4, article 32, 2003. View at Publisher · View at Google Scholar · View at PubMed